Skip to main content
Public Meeting Notice

Public Meeting Notice  Board of Registration in Pharmacy (via Webex) — Thursday, January 11, 2024

Thursday, January 11, 2024 at 8:00 a.m.
Posted: January 2, 2024 12:45 p.m.

Overview   of Board of Registration in Pharmacy (via Webex) — Thursday, January 11, 2024

A meeting of the Board of Registration in Pharmacy: This meeting is open to the public by Webex or telephone.

Join by Webex

Join by telephone

  • +1-617-315-0704 United States Toll (Boston)
  • +1-650-479-3208 United States Toll
  • Access Code: 253 448 67342

Agenda

Time      

#

Item

8:00

I

CALL TO ORDER

8:02

II

APPROVAL OF AGENDA

8:05

III

APPROVAL OF BOARD MINUTES

  • Draft of December 7, 2023, Regular Session Minutes

8:10

IV

REPORTS

  • Applications approved pursuant to Licensure Policy 13-01
  • Monthly report from Probation  
  • Board Delegated Review pursuant to Licensure Policy 14-02
  • PSUD Report-Policy 17-03
  • Research Drug Study report pursuant to Staff Action Policy 18-02

8:15

V

FLEX

  • NABP Annual Meeting; May 14-17, 2024, Fort Worth, TX
  • Discussion of compounding

8:20

VI

APPLICATIONS

  • Cardinal Health – New Wholesale Distributor
  • Dimock Pharmacy- Transfer of Ownership
  • Lynn Community Health – Transfer of Ownership
  • Health Care Technology – WD522- Renovation
  • BWH Outpatient Pharmacy – New Retail Pharmacy
  • MGH Outpatient Pharmacy – New Retail Pharmacy
  • Reliance Care Solutions – New Retail Pharmacy
  • Central Pharmacy – Transfer of Ownership
  • Athol Pharmacy – Transfer of Ownership
  • Chair City Pharmacy – Transfer of Ownership

9:20

VII   

POLICIES

  • Policy 2024-01:  Naloxone Dispensing
  • Policy 2019-02: Automated Dispensing Device Use
  • Policy 2018-01: Permitted Prescription Changes and Additions
  • Rescission of Policy 17-02: Staff Action Approval of Pharmacy Technician Training Programs and Examinations

9:30

VIII

REGULATION

  • 247 CMR 22.00: Monetary Penalties

9:45

IX

VIOLATION OF STAYED PROBATION

  • CVS #1015 DS1534 PHA-2022-0076

10:00

X

RECONSIDERATION

  • The Hilsinger Company Parent LLC, DBA Hilco Vision, PHA-2021-0053, WD517

 

XI

RECONSIDERATION

  • Domenico Carbone, PH16514; PHA-2023-0142

10:15

XII

FILE REVIEW

1

CASE-2023-0456

PHA-2023-0206

Beacon Pharmacy, DS15362

2

CASE-2023-0456

PHA-2023-0207

Garry Levitsky, PH15889

3

CAS-2023-0934

PHA-2023-0196

Optum Infusion Services, DS90100

4

CAS-2023-0596

PHA-2023-0173

Stop & Shop #45, DS1754

5

CAS-2023-0418

PHA-2023-0176

Stop & Shop #64, DS90161

6

CAS-2022-1376

PHA-2022-0207

Nephron SC, Inc, NO00036

7

CASE-2023-1126

PHA-2023-0222

CVS #2177, DS2723

8

CAS-2023-1131

PHA-2023-0188

CVS #8, DS2926

9

CAS-2023-1134

PHA-2023-0191

CVS #634, DS2725

10

CASE-2023-0488

PHA-2023-0227

CVS #11266, DS89870

11

CASE-2023-1036

PHA-2023-0229

CVS #1945, DS3485  

12

CAS-2023-0662

PHA-2023-0213

CVS #1859, DS2945

13

CAS-2023-1132

PHA-2023-0189

CVS #708, DS2706

14

CAS-2023-0937

INV8784

Alana DeSimone, PH239781

15

CAS-2023-1130

PHA-2023-0192

CVS #7109, DS89836

16

CAS-2023-1100

PHA-2023-0187

CVS #2138, DS2815

12:00

 

LUNCH BREAK

12:30

XIIIV

EXECUTIVE SESSION

The Board will meet in Executive Session as authorized pursuant to M.G.L. c. 30A, § 21(a)(1) for the purpose of discussing the reputation, character, physical condition, or mental health, rather than professional competence, of an individual, or to discuss the discipline or dismissal of, or complaints or charges brought against, a public officer, employee, staff member or individual. Specifically, to review a recommendation for suspension, and to evaluate the Good Moral Character as required for registration for a pending applicant. The

1:30

XIV

M.G.L. c. 112, § 65C SESSION

4:00

XV

ADJOURNMENT

Help Us Improve Mass.gov  with your feedback

Please do not include personal or contact information.
Feedback